-
Dec 29, 2012Scientists from GIBH have found new use for cells in human urineThe research group led by Prof Duanqing Pei and Dr Guangjin Pan has found a novel and innovative way to use cells found in human urine that could aid in the treatment of a range of neurodegenerative disorders. In their study, Prof Pei an...
-
Dec 29, 2012Important phenomenon has been discovered by scientists from GIBH in the field of iPSCsRecently, the research group led by Prof Duanqing Pei and Dr Jiekai Chen has discovered that H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.In this study, Prof Pei and Dr Chen demonstrated that there is an epi...
-
Dec 29, 2012Important phenomenon has been discovered by scientists from GIBH in the field of iPSCsRecently, the research group led by Prof Duanqing Pei and Dr Jiekai Chen has discovered that H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.In this study, Prof Pei and Dr Chen demonstrated that there is an epi...
-
Nov 07, 2012Scientists from GIBH have made new achievements in the field of Adenovirus-Vectored VaccinationDr. Chen Ling is a distinguished research fellow at GIBH, CAS. Recently, his group (Dr Sun Caijun and Dr Feng Liqiang) discovered a new technology called AVIP (adenoviral vector-infected PBMC). This technology has been tested in a recogn...
-
Nov 07, 2012Scientists from GIBH have made new achievements in the field of Adenovirus-Vectored VaccinationDr. Chen Ling is a distinguished research fellow at GIBH, CAS. Recently, his group (Dr Sun Caijun and Dr Feng Liqiang) discovered a new technology called AVIP (adenoviral vector-infected PBMC). This technology has been tested in a recogn...
-
Aug 15, 2012GIBH has developed a new chemical class of COX-2 inhibitorsThe international research team, composed of Dr. John J. Talley, Dr. Mark Obukowicz, Dr. Yanmei Zhang, Dr. Zhengchao Tu and Micky Tortorella have developed a new chemical entity as COX-2 inhibitors for the treatment of inflammation and i...